Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -15.43
- Piotroski Score 3.00
- Grade Speculative Buy
- Symbol (BIOL)
- Company BIOLASE, Inc.
- Price $0.06
- Changes Percentage (-8.61%)
- Change -$0.01
- Day Low $0.06
- Day High $0.07
- Year High $1.95
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
- Last Earnings 06/16/2005
- Ex-Dividend for 5/16 Dividend 06/24/2005
- Dividend Payable 07/12/2005
- Today N/A
- Next Earnings (Estimated) 11/06/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$11.97
- Trailing P/E Ratio -0.01
- Forward P/E Ratio -0.01
- P/E Growth -0.01
- Net Income $-20,632,000
Income Statement
Quarterly
Annual
Latest News of BIOL
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Is ADMA Biologics Inc. (ADMA) the Best Performing Small-Cap Stock in 2024?
The article discusses the performance of small-cap stocks in 2024, with a focus on ADMA Biologics Inc. It highlights market trends, insights from Richard Bernstein, and the company's financial growth....
By Yahoo! Finance | 4 days ago -
Millennium Management LLC Acquires Shares in ADMA Biologics Inc
In September 2024, Millennium Management LLC acquired 1,374,038 shares of ADMA Biologics Inc, a biopharmaceutical player, at $19.74 per share, signaling a strategic move into the healthcare industry....
By Yahoo! Finance | 1 week ago -
A Biologist Spotlights The Animal With The Highest 'VO2 Max' (Hint: It's A Type Of Bird)
VO2 max measures an individual's aerobic capacity during intense exercise. Elite athletes have higher values due to genetics and training. Studies show a link between higher VO2 max and longer life ex...
By Forbes | 1 week ago
